(Q44555978)

4 December 2017

title

Oxidation and ubiquitination in neurodegeneration (English)

1 reference

4 December 2017

main subject

protein ubiquitination

1 reference

1 reference

Beat M Riederer

1

1 reference

4 December 2017

Geneviève Leuba

series ordinal

2

1 reference

4 December 2017

Zeinab Elhajj

series ordinal

3

1 reference

4 December 2017

language of work or name

1 reference

1 May 2013

1 reference

Experimental Biology and Medicine

4 December 2017

published in

1 reference

4 December 2017

volume

238

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

519-524

1 reference

The role of the ubiquitin proteasome system in Alzheimer's disease

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

How mitochondria produce reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Quantitative synaptic alterations in the human neocortex during normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Synaptic mitochondrial pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Acetylation of tau inhibits its degradation and contributes to tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Cysteine regulation of protein function--as exemplified by NMDA-receptor modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Proteasome subunit proteins and neuropathology in tauopathies and synucleinopathies: Consequences for proteomic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Proteomics in neurodegeneration--disease driven approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

You say lipofuscin, we say ceroid: defining autofluorescent storage material

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Brain foods: the effects of nutrients on brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Curcumin enhances the polyglutamine-expanded truncated N-terminal huntingtin-induced cell death by promoting proteasomal malfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

The ubiquitin proteasome system in neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Aggresome formation and neurodegenerative diseases: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

In vivo evidence of CHIP up-regulation attenuating tau aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Dopamine oxidation and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Oxidative stress in the progression of Alzheimer disease in the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

The functions of UCH-L1 and its relation to neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Protein quality control in Alzheimer's disease by the ubiquitin proteasome system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Quality control of the proteins associated with neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Selective neuronal degeneration in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Proteasome inhibition and Tau proteolysis: an unexpected regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Peripheral markers in neurodegenerative patients and their first-degree relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Elevated labile Cu is associated with oxidative pathology in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Xanthene food dye, as a modulator of Alzheimer's disease amyloid-beta peptide aggregation and the associated impaired neuronal cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Elevation of glutathione as a therapeutic strategy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

Serial protein labeling with infrared maleimide dyes to identify cysteine modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213488484

21 January 2018

Identifiers

DOI

10.1177/1535370213488484

1 reference

4 December 2017

1 reference